Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
05/06/2004 | US20040087568 Substituted anthranilic amide derivatives and methods of use |
05/06/2004 | US20040087491 Electrophilic ketones for the treatment of herpesvirus infections |
05/06/2004 | US20040087434 Trivalent; oxidation resistance; high activity; forming low and high molecular weight polymers based on ligand structure |
05/06/2004 | US20040086744 Luminance, high purity, low cost, and good thermal stability; as emitters for polymeric light-emitting diodes (PLEDs) |
05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
05/06/2004 | EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
05/06/2004 | EP1414830A1 Tumour inhibiting lanthane compounds |
05/06/2004 | EP1414829A2 Tumour inhibiting cerium compounds |
05/06/2004 | EP1414814A1 6-aryl-4-aminopicolinates and their use as herbicides |
05/06/2004 | EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
05/06/2004 | EP1414802A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
05/06/2004 | EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3 |
05/06/2004 | EP1414800A1 A novel synthesis for heteroarylamine compounds |
05/06/2004 | EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
05/06/2004 | EP1414783A1 Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions |
05/06/2004 | EP1414566A1 Palladium catalysts |
05/06/2004 | EP1414525A2 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide |
05/06/2004 | EP1414450A1 (pyridinyl and pyrimidyl)trienoic acid derivatives as retinoid x receptor modulators |
05/06/2004 | EP1414434A1 Compounds which mimic the chemical and biological properties of discodermolide |
05/06/2004 | EP1414301A1 Pyridylpropynyloxyphenyl derivatives for use as herbicides |
05/06/2004 | EP1326836B1 Process for making 3-amino-2-chloro-4-methylpyridine |
05/06/2004 | EP1233828B1 Chiral catalysts for asymmetric acylation and related transformations |
05/06/2004 | EP1163237B1 Amide derivatives |
05/06/2004 | EP1117645B1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
05/06/2004 | EP1000033B1 Heterocyclic derivatives which inhibit factor xa |
05/06/2004 | EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
05/06/2004 | EP0915825B1 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
05/06/2004 | EP0840727B1 3-hydroxy-2(1h)-pyridinone chelating agents |
05/06/2004 | EP0813409B1 Treatment of cytokine growth factor caused disorders |
05/06/2004 | CA2503588A1 Phenethanolamine derivative for the treatment of respiratory diseases |
05/06/2004 | CA2503245A1 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
05/06/2004 | CA2502819A1 Inhibitors of glycogen synthase kinase 3 |
05/06/2004 | CA2499844A1 Catalyst systems for ethylene oligomerisation to linear alpha olefins |
05/05/2004 | CN1494576A Novel reactive dyes and use thereof for dyeing substrates containing nucleophilic groups |
05/05/2004 | CN1494530A Heterocyclic diamide invertebrate pest control agents |
05/05/2004 | CN1494527A Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds |
05/05/2004 | CN1493561A Preparation of substituted pyridine N-oxide compound |
05/05/2004 | CN1148361C Oxyiminoalkanoic acid derivatives |
05/05/2004 | CN1148356C Benzosulfone derivatives |
05/05/2004 | CN1148355C Pyridazin-3-one derivatives and medicines containing the same |
05/05/2004 | CN1148351C Compound for curing vascular complication, its preparing method and treating use |
05/05/2004 | CN1148346C Hydrazine derivs. |
05/04/2004 | US6730792 β3 adrenergic agonists |
05/04/2004 | US6730786 Process for the preparation of pyrazolopyrimidinones |
05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
05/04/2004 | US6730705 Alkoximino acetic acid amides |
05/04/2004 | US6730686 Methods for inhibiting oxidative modification of proteins |
05/04/2004 | US6730672 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
04/29/2004 | WO2004035737A2 Heterocyclic selective androgen receptor modulators and methods of use thereof |
04/29/2004 | WO2004035589A1 Heterocyclocarboxamide derivatives |
04/29/2004 | WO2004035561A1 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
04/29/2004 | WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
04/29/2004 | WO2004035542A1 Functionalised ionic liquids and method for the production thereof |
04/29/2004 | WO2004035525A1 Inhibitors of histone deacetylase |
04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
04/29/2004 | WO2004035065A1 Hypoglycemic substances containing zinc |
04/29/2004 | WO2004034999A2 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
04/29/2004 | WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
04/29/2004 | WO2004018427A8 O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives |
04/29/2004 | WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions |
04/29/2004 | WO2003099810A3 Radiopharmaceuticals for imaging infection and inflammation |
04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
04/29/2004 | WO2003086282A3 Nitric oxide donors, compositions and methods of use |
04/29/2004 | WO2003028459A8 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
04/29/2004 | WO2002102787A3 Novel sulfonic acid derivatives |
04/29/2004 | WO2002083842A9 Small molecule inhibitors of secretion of proteins encoded by are-mrnas |
04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
04/29/2004 | US20040082798 Novel amino dicarboxylic acid derivatives with pharmaceutical properties |
04/29/2004 | US20040082796 Reacting a substituted benzonitrile with a cysteine compound |
04/29/2004 | US20040082793 Methods of ortho alkylation |
04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
04/29/2004 | US20040082768 Metal chelates and methods of using them for time-resolved fluorescence |
04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |
04/29/2004 | US20040082625 Osteoporosis, bone disorders |
04/29/2004 | US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
04/29/2004 | US20040082611 Novel sulfonyl derivatives |
04/29/2004 | US20040082601 Anti-inflammatory compounds |
04/29/2004 | US20040082597 Use of CRF antagonists and related compositions |
04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |
04/29/2004 | US20040082569 Novel substituted amides, their preparation and use |
04/29/2004 | US20040082553 Novel florfenicol-type antibiotics |
04/29/2004 | US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease |
04/29/2004 | US20040082496 For the treatment of body weight disorders (obesity/anorexia/ bulemia/cachexia) |
04/29/2004 | CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
04/29/2004 | CA2502227A1 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
04/29/2004 | CA2501867A1 Heterocyclic selective androgen receptor modulators and methods of use thereof |
04/29/2004 | CA2501265A1 Inhibitors of histone deacetylase |
04/29/2004 | CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
04/28/2004 | EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
04/28/2004 | EP1412364A1 Platelet adp receptor inhibitors |
04/28/2004 | EP1412343A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
04/28/2004 | EP1412331A1 Process for the production of 4-amino-2,5-bisheterocyclylquinazolines |
04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
04/28/2004 | EP1412326A1 Butyric acid derivatives |
04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
04/28/2004 | EP1411984A2 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
04/28/2004 | EP1411965A1 Methods and compositions for controlling protein assembly or aggregation |
04/28/2004 | EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists |
04/28/2004 | EP1411941A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |